In 2025, Minnesota legislators introduced HF2906, a bill to establish a comprehensive psilocybin therapeutic use program in the state. The bill, now under consideration by the Health, Finance, and Policy Committee in 2026, is not broad legalization but a narrow therapeutic pathway limited to supervised medical use for adults with qualifying medical conditions. D4DPR provided a health-focused analysis to help inform the committee's deliberations, noting that HF2906 offers Minnesota an opportunity to establish a measured, evidence-based framework that better protects both public health and human dignity.
